Tag: acute coronary syndrome

Alirocumab receives EC approval in established atherosclerotic cardiovascular disease

The European Commission (EC) has approved the use of alirocumab (Praluent, Sanofi), a PCSK9 inhibitor, in adults with established atherosclerotic cardiovascular disease (ASCVD) to...

Patients with acute coronary syndrome at increased risk of suicide

Patients with acute coronary syndrome may be at an increased risk for suicide compared to otherwise healthy people, according to new research in the Journal...

Young women with premature acute coronary syndrome now do as well...

It has become commonly accepted that women do worse than men following a heart attack or other coronary event. Earlier studies have documented that...